Novo Nordisk sues rival Eli Lilly over weight loss drug advertising
Summary
Novo Nordisk has filed a lawsuit against Eli Lilly, accusing the company of false advertising about its weight loss drugs. The case claims Eli Lilly used outdated studies to make its drugs seem more effective than Novo Nordisk’s Ozempic.Key Facts
- Novo Nordisk sued Eli Lilly in a New Jersey federal court.
- The lawsuit is about advertising for weight loss drugs.
- Eli Lilly’s drugs mentioned are Mounjaro and Zepbound.
- Novo Nordisk’s drug involved is Ozempic.
- The complaint says Eli Lilly used old studies to exaggerate its drugs’ effectiveness.
- The lawsuit was filed on Tuesday.
- The dispute centers on how well the weight loss drugs help people lose weight.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
